Status:
ACTIVE_NOT_RECRUITING
Comparison of MiSight 1-Day and Acuvue Oasys for Presbyopia in Myopic Children
Lead Sponsor:
Pauline Kang
Collaborating Sponsors:
Johnson & Johnson Vision Care, Inc.
Conditions:
Myopia Progressing
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
This study will compare the effects on myopia progression over the course of one year for eyes wearing MiSight 1 Day contact lenses compared to ACUVUE OASYS for PRESBYOPIA contact lenses.
Eligibility Criteria
Inclusion
- Aged 6-12 years (inclusive)
- Is willing to wear soft contact lenses daily
- Spherical equivalent myopic refractive error between -0.50 to -5.00 D in each eye and astigmatism \< 1.00 D
- Best corrected logMAR visual acuity of 0.1 or better in both eyes
- Good ocular and general health
- No previous use of myopia control interventions for more than 1 month or within the last 30 days
- Competent enough in English to be able to fully understand the participant information and consent form
Exclusion
- Strabismus at distance or near, amblyopia or significant anisometropia (\>1D)
- Systemic or ocular conditions that may affect contact lens use (e.g., allergy) or that may affect refractive development (e.g., ptosis)
- Previous history of ocular surgery, trauma, or chronic ocular disease
- Contraindications to contact lens use
- Ocular or systemic medication use which may interfere or interact with contact lens wear or ocular development
- Plans to migrate or move during the study
- Child, parents or guardians not willing to comply with treatment and/or follow-up schedule
Key Trial Info
Start Date :
February 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06887920
Start Date
February 11 2021
End Date
December 1 2025
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New South Wales
Sydney, New South Wales, Australia, 2052